Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OxyNorm vs Morphine for Cancer Pain
NCT02660229Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxycodone in cancer pain, sponsored by Mundipharma. Started Nov 2015; status: completed.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT02660229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660229.